A digital tool created by a neurologist specializing in multiple sclerosis to help patients, neurologists, and other doctors identify symptoms suggestive of a relapse, with structured logging, risk classification, and a timeline to bring to the medical appointment.
Right in the palm of your hand Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating autoimmune disease of the central nervous system. It predominantly affects women, with symptom onset typically between ages 20 and 40, and is the second most common cause of disability in young adults.
MS is considered a rare disease, with higher prevalence among women, white individuals, and in countries farther from the equator.
Estimated disease prevalence in the city, reflecting the Brazilian reality of multiple sclerosis care.
Initial symptoms usually appear during this stage of life, exactly when early diagnosis has the greatest impact on a patient's future.
Approximately 85% of cases present, at the time of diagnosis, as relapsing-remitting MS (RRMS), characterized by episodes of acute neurological deficits, called relapses, followed by periods of partial or complete clinical remission.
According to the classification by Lublin et al. (2014), a relapse is defined by the emergence of new neurological symptoms or the worsening of previous symptoms, reflecting possible inflammatory activity in the central nervous system.
MS is a treatable disease: highly effective therapies now exist that can change its natural course and reduce the risk of future disability. That's why recognizing a relapse quickly is decisive.
In Brazil, many patients struggle to access neurologists, especially neuroimmunologists. This difficulty, combined with low familiarity among patients and doctors with MS symptoms, directly impacts two fronts of care:
Studies in Brazilian cohorts show a significant gap between symptom onset and diagnosis. Recognizing a relapse can bring forward this investigation and the start of treatment.
In already-diagnosed patients, correctly identifying a new relapse, and telling it apart from pseudo-relapses and paroxysmal symptoms, is key to noticing whether current treatment is failing to control the disease.
Standardizing how a symptom is reported improves the quality of clinical information available for therapeutic decision-making.
A structured questionnaire, built around the main neurological symptoms associated with multiple sclerosis, organized by functional system, to be filled out by the patient or the doctor.
Test Mode or Real Case, and diagnosis status: confirmed, under investigation, or no prior medical evaluation.
Have the symptoms lasted more than 24 hours? Is there fever, a current infection, or recent heat exposure (Uhthoff's phenomenon)?
Detailed selection of the symptoms present, organized into the 8 neurological categories of MS.
The AI analyzes the answers and returns a low, medium, or high relapse risk, along with guidance and an exportable timeline.
Each type of user gets different value from the same structured assessment journey.
Helps recognize whether a new symptom, or the worsening of an old one, has characteristics suggestive of a relapse, and organizes this information into a timeline to bring to the appointment.
Supports the systematization of the patient's report during the visit, reinforcing clinical suspicion of a relapse based on structured criteria.
Since most doctors have limited exposure to MS symptoms during training, Surtômetro helps check whether the reported presentation has characteristics suggestive of a neurological cause.
Free to get started. Create an account to keep all your assessments on record and build an exportable timeline for your medical appointment.
Neurologist specializing in multiple sclerosis · CRM 52929-MG / RQE 30663
The classification system used by Surtômetro was developed under the supervision of a neurologist with extensive experience in multiple sclerosis, based on structured clinical criteria and grounded in scientific evidence available in the literature.
Surtômetro Brazil Observatory. Using the tool also feeds a research project that analyzes real-world data on MS relapses across the country, aiming to help reduce diagnostic delay and inform public health policy for MS care.
More clarity for you, more organized information for your neurologist.
Access Surtômetro